Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels-a single-centre retrospective studyFRONTIERS IN MOLECULAR BIOSCIENCESIF42025-02-130OAAI
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and managementLIVER INTERNATIONALIF5.22024-07-162OAAI
First Report of a Low-Frequency Mosaic Mutation in the Hydroxymethylbilane Synthase Gene Causing Acute Intermittent PorphyriaLIFE-BASELIF3.42023-09-101OAAI
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic ProtoporphyriaLIFE-BASELIF3.42023-04-214OAAI
A novel mutation of porphyria variegate with predominant painful sensorimotor peripheral neuropathy disclosed by post gastric by-pass complications: A case reportJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22021-10-010PRE
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyriaCELL CHEMICAL BIOLOGYIF7.22021-08-0117OAAI
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaNEW ENGLAND JOURNAL OF MEDICINEIF78.52020-06-11389OAAI
Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyriaNUCLEIC ACIDS RESEARCHIF13.12020-04-2019OAAI
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent AttacksHEPATOLOGYIF15.82019-11-07112OAAI
Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62019-10-011PREAI
Management of acute hepatic porphyria attacks in europe and united states: EXPLORE international, prospective, natural history studyJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history studyJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria with recurrent attacksJOURNAL OF HEPATOLOGYIF332018-04-011OAAI
Modeling the ferrochelatase c. 315-48C modifier mutation for erythropoietic protoporphyria (EPP) in miceDISEASE MODELS & MECHANISMSIF3.32017-01-017OAAI
Reference intervals for 24 laboratory parameters determined in 24-hour urine collectionsCLINICAL CHEMISTRY AND LABORATORY MEDICINEIF3.72016-01-0114OAAI
Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyriaBRITISH JOURNAL OF DERMATOLOGYIF9.62015-04-3068PREAI
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyriasJOURNAL OF HEPATOLOGYIF332015-03-0121PREAI
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyriaEXPERT REVIEW OF CLINICAL PHARMACOLOGYIF32014-12-0325PREAI
A bioassay for the detection of neutralizing antibodies against the α-melanocyte stimulating hormone analog afamelanotide in patients with erythropoietic protoporphyriaJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12013-03-016PREAI
Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP)HUMAN MOLECULAR GENETICSIF3.22012-12-2050OAAI